34 funding opportunities are listed in this category
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
Goal: To provide seed funding for early stage drug discovery and development efforts.Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.HeART Award Timeline
Cycle 1 LOIS due: March 26, 2010Applications due: April 26, 2010
Cycle 2
LOIs due: August 16, 2010Applications due: September 30, 2010
International Rett Syndrome Foundation 4600 Devitt DriveCincinnati OH 45246Telephone: 1-800-818-7388Fax: 1-513-874-2520
American Orthopaedic Society for Sports Medicine Sandy Kirkley Clinical Outcome Research Grant
The late Dr. Sandy Kirkley was a passionate advocate for well-conducted randomized controlled trials to evaluate the efficacy of interventions in orthopaedic sports medicine. It was her strong contention that the field must "rise to the challenge of designing and implementing clinical trials that provide the same level of evidence in support of treatments as our nonsurgical colleagues demand." It is one of her intellectual legacies, then, that our profession in general and the Society specifically embrace and support outcome research that has the potential to inform evidence-based practice. To honor the memory and spirit of Dr. Kirkley, AOSSM has established a small grant of $20,000 that would provide start-up, "seed," or supplemental funding for an outcome research project or pilot study. One grant will be awarded each year and eligible applicants are not restricted to newer investigators as is the case for the Young Investigator Grants. All applications must be submitted online. Pre-reviews for the Kirkley grant are also available. To have your application pre-reviewed, please complete a submission online by August 15th.
American Orthopaedic Society for Sports Medicine 6300 N. River Road Suite 500 Rosemont, Illinois 60018
(847) 292-4900
American Orthopaedic Society for Sports Medicine Young Investigator Grant
The Young Investigator Grant provides awards in amounts of up to $40,000 aimed at providing "seed money," or start-up funds, for pilot projects. The principal investigator must be an early career orthopaedic surgeon, fellow, or resident with interests in sports medicine research. Any investigative team seeking such a grant must include at least one member of AOSSM in good standing. All applications must be submitted online. Pre-reviews: In an effort to improve the quality and competitiveness of submissions, the AOSSM Research Committee will pre-review and critique applications prior to the final application deadline. This pre-review is STRONGLY RECOMMENDED but not required. It is anticipated that by participating in the pre-review process, the applicant's chances for funding will improve. The pre-review will focus on: 1) significance of proposed research, 2) scientific quality, 3) statistical methods, 4) realistic nature of goals, 5) long term value of results, and 6) pilot data. Use the online submitter for the pre-review. You must complete an online application by August 15th in order to receive a pre-review. Note: Final submission deadline: December 1st before midnight. Please contact Bart Mann bart@aossm.org at the Society office with any questions.
Lymphangioleiomyomatosis Research Funding
The LAM Foundation is the largest funder of LAM research, outside the National Institutes of Health, committing the majority of the $10.7 million raised to support 79 research projects for the study of LAM. In the first five years of funding LAM research, LAM Foundation scientists reported three major discoveries, including evidence that LAM is genetic, the identification of a LAM gene, and a molecular explanation for abnormal smooth muscle cell growth in LAM. This data resulted in the identification of potential therapy for LAM called sirolimus, or rapamycin, which is currently being tested through clinical trials. LAM Foundation research awards include Post Doctoral Fellowships, Established Investigator Awards, and Pilot Project Awards. The LAM Foundation also partners with the American Thoracic Society (ATS) to co-fund LAM-related research projects. Proposals are submitted to the ATS and reviewed by the ATS Review Board. All scientists who wish to apply for LAM funding must submit a Letter of Intent (LOI).To learn more about LAM Foundation research awards contact:Francis X. McCormack, MDChairman, LAM Foundation Scientific BoardDirector, Division of Pulmonary Critical Care MedicineUniversity of Cincinnati Medical CenterDepartment of MedicineMSB Room 6053 231 Albert Sabin WayCincinnati, OH 45267-0564P: 513-558-4831F: 513-558-4858Email: frank.mccormack@uc.eduTo learn more about ATS LAM funding contact:Monica SimeonavaDirector, ATS Research Program and PARAmerican Thoracic Society61 Broadway, 4th FloorNew York, NY 10006-2755(212) 315-8696msimon@thoracic.org LAM Application deadlineThe fall deadline for LAM grant proposals is September 15th. Letters of intent (LOI) are required prior to submission of grant proposals to The LAM Foundation. LOIs must be sent by July 30th. Letters of Intent will be reviewed by the Scientific Advisory Board (SAB) for scientific merit and alignment with the LAM Foundation mission. SAB invitations to submit full proposals are extended to applicants with proposals that are considered to be competitive by August 15th, but are not a prerequisite for submission. * The fall deadline for full proposals is September 15th. * Applicants will be notified by December 30th * Funding begins in January of the following year.LAM applications should be completed online and sent electronically to sbyrnes@thelamfoundation.org.
Cystic Fibrosis Foundation Pilot and Feasibility Awards and Research Grants
The CF Foundation offers competitive awards for research related to cystic fibrosis. Studies may be carried out at the subcellular, cellular, animal, or patient levels. Two of these funding mechanisms include Pilot and Feasibility Awards and Research Grants. Investigators who seek support from the Foundation under these funding mechanisms must submit a Letter of Intent (LOI) by May 1st. Pilot and Feasibility Awards and Research Grants are issued primarily for basic science research. Those proposals that include methodologies requiring sampling of materials from human subjects will only be considered under this mechanism if the sampling method constitutes minimal patient risk (e.g., venipuncture) and patient samples or data are anonymous. For applications where more invasive procedures are proposed or where patient samples or data will not be anonymous, please submit a Letter of Intent for a Clinical Research Award.
Application SubmissionsLOIs and applications must be submitted electronically at Proposal Central by 5:00pm (EDT) on the deadlines noted below. Letter of Intent for Basic Research A brief description of the proposed research must be submitted in advance for Pilot and Feasibility Award and for Research Grant applications. Please review the Guidelines for complete submission information, as well as a list of research areas currently of interest to the CF Foundation. Pilot and Feasibility Awards Letter of Intent Deadline: May 1st Application Deadline: First Wednesday of October to Proposal Central by 5:00 pm (EDT). These grants are for developing and testing new hypotheses and/or new methods, and to support promising new investigators as they establish themselves in research areas relevant to CF. Proposed work must be hypothesis driven and must reflect innovative approaches to critical questions in CF research. The award is not meant to support continuation of programs begun under other granting mechanisms. Funding priority will be placed on those projects proposing to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat it. Up to $40,000 per year (plus 8% indirects) for two years may be requested.
Research Grants Letter of Intent Deadline: May 1st Application Deadline: First Wednesday of October to Proposal Central by 5:00 pm (EDT). This grant mechanism is intended to encourage the development of new information that contributes to the understanding of the basic etiology and pathogenesis of CF. Funding priority will be placed on those projects proposing to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat it. All proposals must be hypothesis driven, and sufficient preliminary data must be provided to justify CFF support. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH). Support is available for $90,000 per year (plus 8% indirects) for a period of two years, at which time a grant may be competitively renewed for an additional year of funding. Please review the Policies and Guidelines for complete submission information.
For More Information Investigators interested in any of the above-mentioned funding programs may contact the Grants and Contracts Office for further information and/or to discuss the potential relevance of their research to the mission of the CF Foundation and to the objectives of these programs. Please direct inquiries to: Cystic Fibrosis Foundation Grants and Contracts Office 6931 Arlington Road Bethesda, MD 20814 (800) FIGHT CF (301) 951-4422 grants@cff.org
National Ataxia Foundation Research Grant
Letter of Intent Due Date: July 15, 2010Application due: August 15, 2010
In its continuing efforts to find the cause, treatment, and cure for the ataxias, the National Ataxia Foundation(NAF) provides limited, short-term financial support of ataxia research.NAF research grants are for new and innovative studies that are relevant to the cause, pathogenesis or treatmentof the hereditary or sporadic ataxias.
Due to the larger availability of funding for Ataxia- Telangiectasia (A-T), those research proposals willreceive a lower priority. However, a higher ranking will be given to those Ataxia-Telangiectasia research studies which lend themselves to an overall better understanding of the ataxia process.
Research grants are offered primarily as “seed monies” to assist investigators in the early or pilot phase of their studies and as additional support for ongoing investigations on demonstration of need. It is hoped that these studies will be further developed to attract future funding from other sources. Grants are awarded for one year only. If funding for a second year is desired then another grant application should be submitted for that funding period.
The average funds granted will be up to $15,000 but funding may be considered for up to $30,000 for projectsdeserving special consideration.
American Orthotic and Prosthetic Association Request for Pilot Grant Proposals
The American Orthotic & Prosthetic Association is proud to announce a Request for Pilot Grant Proposals in five potential areas of Orthotic and Prosthetic (O&P) research. For 2010-2011, the association is seeking proposals for one-time grants in amounts up to $7,500 for one year.
The leadership of AOPA, working in conjunction with the Center for Orthotic and Prosthetic Learning andOutcomes/Evidence-Based Practice (COPL) and its Board of Directors comprised of representativesfrom eight leading O&P organizations recognizes that there is a modest amount of original evidence-basedor outcomes research in orthotics and prosthetics. Consequently, AOPA is interested in funding original pilot research that will lead to larger trials that may qualify for government or other research funding support in the following four areas:
Areas for submission are:a. AFO treatment of stroke – appropriateness of the 5 custom criteria for custom device useb. Microprocessor Knees and functional value for K 2 patientsc. Residual limb and socket interface selection criteriad. Vacuum assisted socket researche. Prosthetic Foot/ankle mechanisms assessment of current functional classifications
AOPA and the Center will give preference to grants that address evidence-based clinical application inorthotics and prosthetics. Please post this RFP and share it with your colleagues. The deadline for proposals under the Request for Pilot Grant Proposals is April 30, 2010. The study must be completed within 1 year of the date of the award.Inquiries should be sent in writing to:Thomas F. Fise, Executive DirectorAmerican Orthotic & Prosthetic Association330 John Carlyle Street, Suite 200, Alexandria, VA 22314P: 571-431-0802 F: 571-431-0899
www.AOPAnet.org EligibilityNote that in addition to O&P professionals, physicians in training (interns, residents, fellows) are eligible to apply, provided that the work is conducted under the preceptorship of a more senior or experienced investigator. Successful applicants must agree to acknowledge the AOPA support in any publications or presentations that result from the research, and to submit a final report within 12 monthsof the date of the award.
Selection CriteriaAwardees will be selected based on feasibility, scientific and clinical significance, originality, and anticipated contribution of the research to clinical practice. Applications will also be evaluated on the availability of adequate resources, including personnel and facilities.
Review ProcessAOPA will submit applications to the Center for O&P Learning’s (COPL) Board of Directors which will review the grant proposals and provide input and recommendations to the AOPA Board of Directors, which shall have the final decision on whether any research can be funded and in what amount.
DeadlineAn original and 5 copies of the completed application package must be received by April 30, 2010. Successful applicants will be notified by June 15, 2010, with availability of this support to take place as shortly thereafter as feasible.
Prevention Above All Discoveries Grants
Supporting the adoption of solutions into everyday clinical practiceLetter of intent submissions dates November 1, 2009 thru March 31, 2010QuestionsSend submissions/questions to Toni Marchinski, grant coordinator, at grantprogram@medline.com or call 866-941-1998 for more information.Medline is committing up to $1 million in total costs over several years to stimulate the gathering of solid evidence that supports the adoption of solutions into clinical practice. A review panel, whose members represent a breadth of research and practice knowledge, will select grant recipients to be awarded up to $25,000 each for pilot grants or $100,000 each for an empirical study.
Objectives * To stimulate research that will lead to the development of new targeted interventions aimed at reducing medical risks and harms associated with hospital-acquired conditions (identified by CMS in 2008 IPPS final rule). * To test the costs and effectiveness of interventions and programs designed to reduce the incidence of hospital-acquired conditions. * To disseminate practical, evidence-based solutions within and across hospitals, leading to a reduction in hospital-acquired conditions.These awards are designed to assist healthcare providers in developing and testing creative solutions or interventions for reducing or preventing hospital-acquired harms. Recipients of grant awards will be paired with a research mentor/consultant through the grant program to develop methods and guide the conduct of the study, ensuring that a rigorous research process is followed. These studies can be small pilot studies aimed at developing and testing the feasibility of new solutions or larger evaluation studies to more fully test the costs, effectiveness or dissemination of evidence-based solutions.
Award Process 1. In response to our request for applications (RFA), providers will submit a 2-3 page letter of intent providing the following information: * The HAC(s) that the study will address * Whether the letter is for a pilot study or empirical study * The proposed solution * The objective of the study * The proposed approach in as much detail as you have thought it through at this point * Expected output of the study * Brief biography about the individuals involved, including any experience in the area of focus * Budget estimate, including the major expenditure categories 2. The review committee will review all LOI’s received after the March 31, 2010 deadline. Acceptable letters will be assigned to the most appropriate research mentor, who will contact the applicant and work with him/her to develop the letter into a full proposal of 5-7 pages in length, including a complete budget. Proposal and budget guidelines will be sent after approval of letter of intent. 3. The review committee will review full proposals and budgets on a rolling basis. Most of the projects that are chosen for full proposal submission will be funded; however, this process may involve a subsequent resubmission of a revised proposal so that the funded research plan is clear. 4. Pilot grants will generally be up to six months in duration with a budget of about $25,000. Empirical studies can be up to $100,000 and last about a year in duration. Pilot study grantees can go on to submit an empirical study grant at the successful conclusion of the pilot project, or applicants can apply for a full empirical study grant based on their initial letter of intent if they have an existing practice with some evidence base that they wish to evaluate. 5. The final report for a pilot grant study should be a brief paper written for a Medline publication (Healthy Skin, The OR Connection or Infection Prevention Now) whether or not the grant is successful. The final report for an empirical study is a paper to be submitted for publication in a peer-reviewed journal.
Medline Industries, Inc.One Medline Place Mundelein, Illinois 600601-800-MEDLINEFax: 1-800-351-1512info@medline.com
1234next
